Adam J. Townsend

Insider Reports History

Location
Crestwood, KY
Signature
/s/ David Watson, attorney-in-fact for Adam Townsend
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adam J. Townsend:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Chief Commercial Officer Common Stock 84,050 $2,481,459 $29.52 29 Jan 2025 Direct

Insider Reports Filed by Adam J. Townsend

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLS Apellis Pharmaceuticals, Inc. 29 Jan 2025 1 -$20,519 4 Chief Commercial Officer 30 Jan 2025, 12:18
APLS Apellis Pharmaceuticals, Inc. 22 Jan 2025 1 -$101,104 4 Chief Commercial Officer 23 Jan 2025, 15:39
APLS Apellis Pharmaceuticals, Inc. 17 Jan 2025 1 -$65,938 4 Chief Commercial Officer 21 Jan 2025, 16:12
APLS Apellis Pharmaceuticals, Inc. 13 Jan 2025 1 -$77,065 4 Chief Commercial Officer 14 Jan 2025, 16:29
APLS Apellis Pharmaceuticals, Inc. 12 Feb 2024 1 -$77,796 4 Chief Commercial Officer 13 Feb 2024, 17:05
APLS Apellis Pharmaceuticals, Inc. 29 Jan 2024 1 -$58,109 4 Chief Commercial Officer 31 Jan 2024, 16:36
APLS Apellis Pharmaceuticals, Inc. 22 Jan 2024 1 -$221,831 4 Chief Commercial Officer 23 Jan 2024, 18:15
APLS Apellis Pharmaceuticals, Inc. 16 Jan 2024 3 +$2,140,221 4 Chief Commercial Officer 17 Jan 2024, 16:37
APLS Apellis Pharmaceuticals, Inc. 01 Dec 2023 4 -$5,029,403 4 Chief Commercial Officer 05 Dec 2023, 19:29
APLS Apellis Pharmaceuticals, Inc. 03 May 2023 3 -$338,100 4 Chief Commercial Officer 04 May 2023, 16:40
APLS Apellis Pharmaceuticals, Inc. 03 Apr 2023 3 -$294,800 4 Chief Commercial Officer 05 Apr 2023, 16:50
APLS Apellis Pharmaceuticals, Inc. 03 Mar 2023 3 -$243,750 4 Chief Commercial Officer 07 Mar 2023, 15:53
APLS Apellis Pharmaceuticals, Inc. 21 Feb 2023 3 -$60,898 4 Chief Commercial Officer 22 Feb 2023, 05:36
APLS Apellis Pharmaceuticals, Inc. 10 Feb 2023 1 -$40,046 4 Chief Commercial Officer 14 Feb 2023, 16:03
APLS Apellis Pharmaceuticals, Inc. 03 Feb 2023 3 -$203,800 4 Chief Commercial Officer 06 Feb 2023, 16:35
APLS Apellis Pharmaceuticals, Inc. 27 Jan 2023 1 -$29,076 4 Chief Commercial Officer 30 Jan 2023, 16:07
APLS Apellis Pharmaceuticals, Inc. 20 Jan 2023 1 -$99,520 4 Chief Commercial Officer 24 Jan 2023, 16:32
APLS Apellis Pharmaceuticals, Inc. 12 Jan 2023 2 +$2,274,017 4 Chief Commercial Officer 17 Jan 2023, 18:44
APLS Apellis Pharmaceuticals, Inc. 03 Jan 2023 3 -$178,050 4 Chief Commercial Officer 05 Jan 2023, 19:00
APLS Apellis Pharmaceuticals, Inc. 05 Dec 2022 3 -$327,350 4 Chief Commercial Officer 07 Dec 2022, 07:30
APLS Apellis Pharmaceuticals, Inc. 03 Nov 2022 3 -$368,150 4 Chief Commercial Officer 07 Nov 2022, 15:19
APLS Apellis Pharmaceuticals, Inc. 03 Oct 2022 3 -$258,000 4 Chief Commercial Officer 05 Oct 2022, 17:12
APLS Apellis Pharmaceuticals, Inc. 06 Sep 2022 3 -$226,450 4 Chief Commercial Officer 07 Sep 2022, 16:37
APLS Apellis Pharmaceuticals, Inc. 15 Aug 2022 3 -$673,875 4 Chief Commercial Officer 16 Aug 2022, 17:04
APLS Apellis Pharmaceuticals, Inc. 11 Aug 2022 3 -$648,875 4 Chief Commercial Officer 12 Aug 2022, 17:01
APLS Apellis Pharmaceuticals, Inc. 08 Aug 2022 3 -$623,875 4 Chief Commercial Officer 09 Aug 2022, 17:22
APLS Apellis Pharmaceuticals, Inc. 03 Aug 2022 3 -$206,700 4 Chief Commercial Officer 04 Aug 2022, 18:40
APLS Apellis Pharmaceuticals, Inc. 21 Apr 2022 5 -$166,650 4 Chief Commercial Officer 12 Jul 2022, 17:55
APLS Apellis Pharmaceuticals, Inc. 10 Feb 2022 1 -$42,172 4 Chief Commercial Officer 14 Feb 2022, 15:34
APLS Apellis Pharmaceuticals, Inc. 28 Jan 2022 1 -$30,872 4 Chief Commercial Officer 01 Feb 2022, 17:01
APLS Apellis Pharmaceuticals, Inc. 21 Jan 2022 2 $0 4 Chief Commercial Officer 25 Jan 2022, 15:55